Polypoidal choroidal vasculopathy: recent advances in therapy.
Polypoidal Choroidal Vasculopathy (PCV) is a condition characterized by chronic, multiple, recurrent serous and/or hemorrhagic detachments of the retinal pigment epithelium (RPE) and neurosensory retina. Although it has been described to more often affect Asians and individuals of pigmented races, PCV may also be present in white patients who present with the clinical appearance of age related macular degeneration (AMD). PCV and its treatment are discussed, including the use of combination therapy.
de Crecchio
G
G
Dipartimento di Oftalmologia, Università degli Studi di Napoli "Federico II", Naples, Italy.
Chan
R V P
RV
Manzi
G
G
Romano
M R
MR
D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D001766:Blindness / Q000517:prevention & control; D002829:Choroid / Q000098:blood supply; D015862:Choroid Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D003131:Combined Modality Therapy; D006801:Humans; D017075:Laser Coagulation; D016491:Peripheral Vascular Diseases / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D010778:Photochemotherapy; D017319:Photosensitizing Agents / Q000627:therapeutic use; D011127:Polyps / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology / Q000628:therapy; D011166:Porphyrins / Q000627:therapeutic use; D012163:Retinal Detachment / Q000209:etiology; D042442:Vascular Endothelial Growth Factors / Q000037:antagonists & inhibitors; D000077362:Verteporfin
D020533:Angiogenesis Inhibitors; D017319:Photosensitizing Agents; D011166:Porphyrins; D042442:Vascular Endothelial Growth Factors; D000077362:Verteporfin